Lyra Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYRA and other ETFs, options, and stocks.About LYRA
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases.
CEOMaria Palasis
CEOMaria Palasis
Employees30
Employees30
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2005
Founded2005
Employees30
Employees30
LYRA Key Statistics
Market cap5.66M
Market cap5.66M
Price-Earnings ratio-0.14
Price-Earnings ratio-0.14
Dividend yield—
Dividend yield—
Average volume38.03K
Average volume38.03K
High today$3.29
High today$3.29
Low today$3.13
Low today$3.13
Open price$3.13
Open price$3.13
Volume38.99K
Volume38.99K
52 Week high$37.50
52 Week high$37.50
52 Week low$3.10
52 Week low$3.10
Stock Snapshot
Lyra Therapeutics(LYRA) stock is priced at $3.25, giving the company a market capitalization of 5.66M. It carries a P/E multiple of -0.14.
On 2025-11-21, Lyra Therapeutics(LYRA) stock moved within a range of $3.13 to $3.29. With shares now at $3.25, the stock is trading +3.9% above its intraday low and -1.2% below the session's peak.
Trading volume for Lyra Therapeutics(LYRA) stock has reached 38.99K, versus its average volume of 38.03K.
Over the past 52 weeks, Lyra Therapeutics(LYRA) stock has traded between a high of $37.50 and a low of $3.10.
Over the past 52 weeks, Lyra Therapeutics(LYRA) stock has traded between a high of $37.50 and a low of $3.10.
People also own
Based on the portfolios of people who own LYRA. This list is generated using Robinhood data, and it’s not a recommendation.